AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Serum levels of HCV RNA and core protein before and after incubation at 37degrees C for 24 h
Authors: Nakamuta, M Shimohashi, N Tada, S Kinukawa, N Enjoji, M Uchimura, K Motomura, K Sugimoto, R Kato, M Iwamoto, H Kuniyoshi, M Sakai, H Nawata, H
Citation: M. Nakamuta et al., Serum levels of HCV RNA and core protein before and after incubation at 37degrees C for 24 h, HEPATOL RES, 19(3), 2001, pp. 254-262
Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats
Authors: Nakamuta, M Ohta, S Tada, S Tsuruta, S Sugimoto, R Kotoh, K Kato, M Nakashima, Y Enjoji, M Nawata, H
Citation: M. Nakamuta et al., Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats, INT J MOL M, 8(5), 2001, pp. 553-560
The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats
Authors: Koyanagi, T Nakamuta, M Enjoji, M Iwamoto, H Motomura, K Sakai, H Nawata, H
Citation: T. Koyanagi et al., The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats, INT J MOL M, 7(3), 2001, pp. 321-327
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma
Authors: Kuniyoshi, M Nakamuta, M Sakai, H Enjoji, M Kinukawa, N Kotoh, K Fukutomi, M Yokota, M Nishi, H Iwamoto, H Uike, N Nishimura, J Inaba, S Maeda, Y Nawata, H Muta, K
Citation: M. Kuniyoshi et al., Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma, J GASTR HEP, 16(2), 2001, pp. 215-219
Kinetics of the hepatitis C virus during interferon therapy as a marker oftherapeutic response
Authors: Nakamuta, M Fukutomi, T Shimohashi, N Kinukawa, N Uchimura, K Tada, S Motomura, K Enjoji, M Kato, M Iwamoto, H Tanabe, Y Imari, Y Sakamoto, S Sakai, H Nawata, H
Citation: M. Nakamuta et al., Kinetics of the hepatitis C virus during interferon therapy as a marker oftherapeutic response, J GASTR HEP, 16(1), 2001, pp. 29-33
Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma
Authors: Noguchi, K Enjoji, M Nakamuta, M Nakashima, M Nishi, H Choi, I Taguchi, K Kotoh, K Shimada, M Sugimachi, K Tsuneyoshi, M Nawata, H Watanabe, T
Citation: K. Noguchi et al., Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma, CANCER LETT, 168(2), 2001, pp. 197-202
Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells
Authors: Uchimura, K Nakamuta, M Enjoji, M Irie, T Sugimoto, R Muta, T Iwamoto, H Nawata, H
Citation: K. Uchimura et al., Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells, HEPATOLOGY, 33(1), 2001, pp. 91-99
Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same origin
Authors: Fukutomi, M Enjoji, M Iguchi, H Yokota, M Iwamoto, H Nakamuta, M Sakai, H Nawata, H
Citation: M. Fukutomi et al., Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same origin, CELL BIOC F, 19(1), 2001, pp. 65-68
Hepatic epithelioid hemangioendothelioma
Authors: Uchimura, K Nakamuta, M Osoegawa, M Takeaki, S Nishi, H Iwamoto, H Enjoji, M Nawata, H
Citation: K. Uchimura et al., Hepatic epithelioid hemangioendothelioma, J CLIN GAST, 32(5), 2001, pp. 431-434
Serum leptin levels in patients with nonalcoholic chronic liver disease
Authors: Nakamuta, M Tada, S Uchimura, K Enjoji, M Kinukawa, N Iwamoto, H Sugimoto, R Shimada, M Ohashi, M Sugimachi, K Nawata, H
Citation: M. Nakamuta et al., Serum leptin levels in patients with nonalcoholic chronic liver disease, HEP-GASTRO, 48(38), 2001, pp. 527-532
A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats
Authors: Tada, S Iwamoto, H Nakamuta, M Sugimoto, R Enjoji, M Nakashima, Y Nawata, H
Citation: S. Tada et al., A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats, J HEPATOL, 34(4), 2001, pp. 529-536
Decline of hepatitis C virus load in serum during the first 24 h after administration of in interferon-beta as a predictor of the efficacy of therapy
Authors: Fukutomi, T Nakamuta, M Fukutomi, M Iwao, M Watanabe, H Hiroshige, K Tanabe, Y Nawata, H
Citation: T. Fukutomi et al., Decline of hepatitis C virus load in serum during the first 24 h after administration of in interferon-beta as a predictor of the efficacy of therapy, J HEPATOL, 34(1), 2001, pp. 100-107
A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing
Authors: Lau, PP Villanueva, H Kobayashi, K Nakamuta, M Chang, BHJ Chan, L
Citation: Pp. Lau et al., A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing, J BIOL CHEM, 276(49), 2001, pp. 46445-46452
Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells
Authors: Enjoji, M Kotoh, K Iwamoto, H Nakamuta, M Nawata, H
Citation: M. Enjoji et al., Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells, IN VITRO-AN, 36(2), 2000, pp. 71-73
Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: Production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model
Authors: Enjoji, M Wang, F Nakamuta, M Chan, L Teng, BB
Citation: M. Enjoji et al., Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: Production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model, HUM GENE TH, 11(17), 2000, pp. 2415-2430
Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia
Authors: Ishikawa, F Nakamuta, M Kato, M Iwamoto, H Enjoji, M Miyata, Y Inoguchi, T Sakai, H Nawata, H
Citation: F. Ishikawa et al., Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia, INTERN MED, 39(11), 2000, pp. 925-929
Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells
Authors: Enjoji, M Nakashima, M Nakamuta, M Nawata, H
Citation: M. Enjoji et al., Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells, JPN J CANC, 91(2), 2000, pp. 223-230
Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of Jun-N-terminal kinase and the NF-kappa B signaling pathway in rat Kupffer cells
Authors: Shimohashi, N Nakamuta, M Uchimura, K Sugimoto, R Iwamoto, H Enjoji, M Nawata, H
Citation: N. Shimohashi et al., Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of Jun-N-terminal kinase and the NF-kappa B signaling pathway in rat Kupffer cells, J CELL BIOC, 78(4), 2000, pp. 595-606
A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth
Authors: Iwamoto, H Nakamuta, M Tada, S Sugimoto, R Enjoji, M Nawata, H
Citation: H. Iwamoto et al., A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth, J HEPATOL, 32(5), 2000, pp. 762-770
Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth
Authors: Iwamoto, H Nakamuta, M Tada, S Sugimoto, R Enjoji, M Nawata, H
Citation: H. Iwamoto et al., Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth, J LA CL MED, 135(5), 2000, pp. 406-412
Serum level of interleukin-4 is a possible marker of therapeutic response to interferon treatment in patients with chronic hepatitis C
Authors: Higashi, N Nakamuta, M Motomura, K Enjoji, M Sakai, H Nawata, H
Citation: N. Higashi et al., Serum level of interleukin-4 is a possible marker of therapeutic response to interferon treatment in patients with chronic hepatitis C, J HEPATOL, 31(2), 1999, pp. 383-383
Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells
Authors: Kato, M Iwamoto, H Higashi, N Sugimoto, R Uchimura, K Tada, S Sakai, H Nakamuta, M Nawata, H
Citation: M. Kato et al., Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells, J HEPATOL, 31(1), 1999, pp. 91-99
Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells
Authors: Iwamoto, H Sakai, H Kotoh, K Nakamuta, M Nawata, H
Citation: H. Iwamoto et al., Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells, DIG DIS SCI, 44(5), 1999, pp. 1038-1045
Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion
Authors: Iwamoto, H Sakai, H Tada, S Nakamuta, M Nawata, H
Citation: H. Iwamoto et al., Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion, J LA CL MED, 134(1), 1999, pp. 83-89
Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein low density lipoprotein production in a viable conditional knockout mouse
Authors: Chang, BHJ Liao, W Li, L Nakamuta, M Mack, D Chan, L
Citation: Bhj. Chang et al., Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein low density lipoprotein production in a viable conditional knockout mouse, J BIOL CHEM, 274(10), 1999, pp. 6051-6055
Risultati: 1-25 | 26-27